1A,2,3,9C-TETRAHYDRO-OXIRENO(3,4)BENZO(1,2-H)QUINOLINE-2,3-DIOL, (1AR,2R,3S,9CS)-(+/-)-
UNII L5DEC19M1Q
Substance Identification & Data
This profile provides standardized clinical and technical data for 1a,2,3,9c-tetrahydro-oxireno(3,4)benzo(1,2-h)quinoline-2,3-diol, (1ar,2r,3s,9cs)-(+/-)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L5DEC19M1Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 113163-22-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C13H11NO3 UGQWYQLYNQTXMZ-XQHKEYJVSA-N;UGQWYQLYNQTXMZ-QNWHQSFQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1a,2,3,9c-tetrahydro-oxireno(3,4)benzo(1,2-h)quinoline-2,3-diol, (1ar,2r,3s,9cs)-(+/-)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.